Society for Translational Oncology
Nonprofit profile at a glance
- EIN
- 203186261
- IRS 990 coverage
- 2011–2025
- Official website data refreshed
- Sep 2026
- Forms available
- Form 990 2025
- Location
- Durham, NC, USA
- Phone
- 9196415323
- Rating
- 69
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Cancer Research
Reported finances
- Revenue
- $289,410
- Expenses
- $536,505
- Assets
- $1,266,853
- Liabilities
- $67,642
Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
7 people listed
Executive titles in this filing
- Ann Murphy PHD (Executive Director)
People named in this filing
- Ann Murphy PHD (Executive Director)
- Martin J Murphy DMEDSC PHD FASCO (Chairman)
- Kenneth B Lee MBA (Treasurer)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization dedicated to translating cancer research into clinical practice.
What it reported doing in 2025
The Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization that promotes high-quality, equitable patient care and fosters the discovery and clinical translation of important new therapies that enhance the practice of global oncology as well as supports the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems, thus helping protect the vulnerable from life-threatening infections. STO bridges a translational gap between drug discovery and approved drug delivery with a portfolio of educational activities for physicians and other members of the healthcare team. STO's decades-long commitment to translational research and education includes fellowships in both cancer and infectious diseases. The latter has become a critical STO commitment during the COVID-19 pandemic from the global genesis to worldwide distribution of new vaccines and improved therapeutics. STO is committed to diversity, inclusivity, and equity throughout our programs.
Operating model
- Revenue model
- Mixed. Its operating money came from several sources; no one source provided a clear majority.
- Distribution model
- Direct operator. The filing allocates 99% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of total spending goes to programs and some filing-based governance responses are negative or unanswered.
Rating breakdown
- Financial Efficiency: 56
- Transparency & Controls: 92
- Accountability: 82
- Sustainability: 31
- Growth: 20
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 77.4%; rating input score 77
- Program expense ratio: 39.6%; rating input score 40
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 64th percentile among comparable filings
- Pay-setting controls: Limited
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
- Governance controls: 4 of 7 controls in place; rating input score 57
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Fail
- CEO compensation review process: NotApplicable
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: -85.4%; rating input score 2; 2nd percentile among comparable filings
- Total-asset coverage ratio: 2.36; rating input score 63; 63rd percentile among comparable filings
- Liabilities to assets ratio: 0.05; rating input score 27; 27th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 67; 67th percentile among comparable filings
Growth
- Program expense growth: -12.9% per year; rating input score 0; 9th percentile among comparable filings
- Revenue growth: -6.6% per year; rating input score 0; 7th percentile among comparable filings
- Asset growth: 6.4% per year; rating input score 100; 50th percentile among comparable filings
Details
- What they do: 9 programs and campaigns described on the official site · 2 operating locations identified
- Where the money goes: 77.4% of revenue deployed · 39.6% of spending went to programs
- Governance: 7 of 7 board members independent · 4 of 7 filing controls reported
- Programs: 3 filed program accomplishments · $212K in reported program spending
- Leadership: top reported pay $0 · 7 people listed
- Consistency: 28 of 28 current checks pass
- Schedules: 5 filed schedules · includes major donors
- Filing history: 8 filing years from 2011 to 2025
- Contacts: How to reach this organization
- Related organizations: 1 filed related-organization link
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Moderate — Financial Efficiency: Program expense ratio scored 40/100.
- Review — Accountability: Governance controls: 2 of 6 not reported.
- High — Sustainability: Operating margin scored 2/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Liabilities to assets ratio scored 27/100.